JG
RCEL icon

Jain Global’s Avita Medical RCEL Stock Holding History

Jain Global’s Portfolio RCEL Stock Details RCEL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$127K Buy
+30,775
New +$133K ﹤0.01% 1580
2026
Q1 		– Sell
-24,168
Closed -$83.4K – 1567
2025
Q4 		$83.4K Buy
+24,168
New +$96.4K ﹤0.01% 1122

Other funds holding RCEL

Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
NA
NewEdge Advisors New Orleans, Louisiana $33.6B AUM 31.03% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Jain Global's RCEL Position: Q2 2026 in Review

Jain Global opened a new position in Avita Medical (RCEL) in Q2 2026: 30,775 shares worth $127K. The stake represents ﹤0.01% of the portfolio and ranks #1580 among its holdings. This is a return to the name: Jain Global previously reported a position in RCEL as recently as Q4 2025.

Jain Global first reported a position in RCEL in Q4 2025 and has held it in 2 quarters since. 74 funds tracked by Wall St. Rank hold RCEL as of Q2 2026.

  • Jain Global held 30,775 shares of Avita Medical worth $127K as of Q2 2026.
  • Avita Medical was a new Jain Global position in Q2 2026.
  • Avita Medical made up ﹤0.01% of Jain Global's portfolio in Q2 2026, its #1580 holding.
  • Jain Global first reported a position in Avita Medical in Q4 2025 and has held it in 2 quarters since.
  • 74 funds tracked by Wall St. Rank held Avita Medical as of Q2 2026.

Based on Jain Global's 13F filing for Q2 2026, filed 14 Aug 2026.